Tag Archives: PRXL

PAREXEL International Corporation (PRXL)

PAREXEL International Corporation, a biopharmaceutical services company, provides a range of clinical research, medical communications, consulting, commercialization, and technology products and services to the pharmaceutical, biotechnology, and medical device industries worldwide. The company operates in three segments: Clinical Research Services (CRS), PAREXEL Consulting and Medical Communications Services (PCMS), and Perceptive Informatics (Perceptive). The CRS segment offers clinical trials management, observational studies, patient/disease registries and post-marketing surveillance, data management and biostatistics, epidemiology and health economics/outcomes research, clinical logistics, and clinical pharmacology, as well as related medical advisory, patient recruitment, and investigator site services. This segment also manages various aspects of clinical trials, including study and protocol design; case report form design; paper or electronic questionnaires designed for use in clinical research; site and investigator recruitment; patient enrollment; study monitoring and data collection; data analysis; report writing; and medical services. The PCMS segment provides technical expertise and advice in various areas comprising drug development, regulatory affairs, product pricing and reimbursement, and GMP compliance; market development, product development, and targeted communications services in support of product launch. In addition, its consultants identify alternatives and propose solutions to address clients? product development, registration, and commercialization issues. The Perceptive segment provides information technology solutions comprising medical imaging and systems integration services; ClinPhone RTSM, CTMS, and EDC products; Web-based portals; systems integration; and patient diary applications. PAREXEL International Corporation was founded in 1983 and is headquartered in Waltham, Massachusetts.

News about PRXL

PAREXEL International (PRXL) Earning Somewhat Favorable Media Coverage, Report Shows
News headlines about PAREXEL International (NASDAQ:PRXL) have trended somewhat positive on Tuesday, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by reviewing more than twenty million blog and news sou...Read More>>>

Ubs Oconnor Llc Buys Reynolds American Inc, Air Products & Chemicals Inc, Delta Air Lines Inc, Sells
Chicago, IL, based Investment company Ubs Oconnor Llc buys Reynolds American Inc, Air Products & Chemicals Inc, Delta Air Lines Inc, CarMax Inc, Restaurant Brands International Inc, Danaher Corp, Range Resources Corp, Verizon Communications Inc, ...Read More>>>

Vanguard Health Care Fund Buys Abbott Laboratories, Baxter International Inc, Teva Pharmaceutical In
Investment company Vanguard Health Care Fund buys Abbott Laboratories, Baxter International Inc, Teva Pharmaceutical Industries, Becton, Dickinson and Co, Sysmex Corp, Tesaro Inc, Terumo Corp, Shanghai Fosun Pharmaceutical (Group) Co, Idorsia, WuXi B...Read More>>>

The Short Case For Medpace
Target Price and Rationale Target price of $22. Medpace's (NASDAQ:MEDP) revenue will be flat in 2017 driven by its largest customer (10% of revenues) pulling back spending. This revenue will not be made up by other customers as the funding environmen...Read More>>>

INC Research Looks Like A More Focused, Higher-Risk CRO Option
As I said in a recent piece on PRA Health Sciences (NASDAQ:PRAH), there's a lot to like about the contract research organization (or CRO) sector as trial complexity increases, R&D budgets continue to grow, and drug companies look to shift toward ...Read More>>>